| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/01/1993 | EP0557300A1 Bispecific antibodies, method of production, and uses thereof |
| 09/01/1993 | EP0557273A1 Rat thyrotropin receptor gene and uses thereof |
| 09/01/1993 | EP0434675B1 Polypeptide compounds having growth hormone releasing activity |
| 09/01/1993 | EP0343258B1 Agent for prophylaxis and treatment of virally infected diseases |
| 09/01/1993 | EP0241539B1 Expression systems for overproduction of desired proteins |
| 09/01/1993 | CN1021973C Production of proteins in procaryotes |
| 08/31/1993 | US5241052 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 08/31/1993 | US5241051 Secreted by human erythroblastoid cells |
| 08/31/1993 | US5241049 Neutrophil chemoattractants |
| 08/31/1993 | US5240924 N-acylamino acid derivatives and their use |
| 08/31/1993 | US5240913 Inhibitors of thrombin |
| 08/31/1993 | US5240912 Transforming growth factor (TGF) peptides |
| 08/31/1993 | US5240911 Method of reducing blood sugar levels using a hypoglycemic agent |
| 08/31/1993 | US5240910 Cyclic depsipeptide as endothelin antagonist |
| 08/31/1993 | US5240909 Use of lactoferrin for treatment of toxic effects of endotoxins |
| 08/31/1993 | US5240848 Cloning; genetic engineering |
| 08/31/1993 | US5240847 Cloned gene |
| 08/31/1993 | US5240846 Gene therapy vector for cystic fibrosis |
| 08/31/1993 | US5240841 E. coli resistance to Qβ virus infection |
| 08/31/1993 | US5240833 Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides |
| 08/31/1993 | US5240704 Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans |
| 08/31/1993 | US5240701 Method of performing angioplasty procedures |
| 08/26/1993 | DE4204951A1 Orthopaedic padding with additional healing effect - comprises collagen impregnated with linseed, bracken, camomile, etc., used in cushions, mattresses, etc. |
| 08/25/1993 | EP0557199A1 Polyethyleneglycol hirudin conjugate, process of preparation and use in the cure of thrombosis |
| 08/25/1993 | EP0557148A1 Process for the preparation of a dietary supplement from embryonic tissues |
| 08/25/1993 | EP0557076A1 Selective removal of N-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
| 08/25/1993 | EP0557042A1 Cosmetic and/or pharmaceutical compositions and methods for their use in protecting tissues from contact with heavy metals |
| 08/25/1993 | EP0556962A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/25/1993 | EP0556482A2 Propyl endopeptidase inhibitor |
| 08/25/1993 | EP0556405A1 Pseudopentapeptides with immunomodulating activity |
| 08/25/1993 | EP0556395A1 Novel cytokine |
| 08/25/1993 | EP0556388A1 Antiviral agent |
| 08/25/1993 | EP0556345A1 Retroviral vectors useful for gene therapy. |
| 08/25/1993 | EP0556344A1 New insulin-like growth factor binding protein (igfbp-6) |
| 08/25/1993 | EP0556339A1 Chinese hamster ovary cell retrovirus-like c particles |
| 08/25/1993 | EP0556328A1 Bridging antibody fusion constructs |
| 08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
| 08/25/1993 | EP0556231A1 Method and composition for controlling proliferation of cells |
| 08/25/1993 | EP0556207A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 08/25/1993 | EP0556204A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies |
| 08/25/1993 | EP0556182A1 Dna capable of site-specific integration into mycobacteria |
| 08/25/1993 | EP0556178A1 Use of protease nexin-i to mediate wound healing |
| 08/25/1993 | EP0556171A1 Growth hormone antagonists |
| 08/25/1993 | EP0483271B1 Peptides containing diamino-glycols as transition-state mimics |
| 08/25/1993 | EP0440625B1 Heparin-containing formulations |
| 08/24/1993 | US5239078 Matrix metalloprotease inhibitors |
| 08/24/1993 | US5239061 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
| 08/24/1993 | US5239059 Ion-channel forming peptides |
| 08/24/1993 | US5239058 Selectively inhibit coagulation factor Xa |
| 08/24/1993 | US5238963 Treatment with compound to prevent crosslinking of glycosylation products |
| 08/24/1993 | US5238931 Treating diarrhea |
| 08/24/1993 | US5238926 Anti-fungal agents |
| 08/24/1993 | US5238925 Angiogenic factor isolated from live yeast cell derivatives and its use in treating wounds or burns in mammals |
| 08/24/1993 | US5238924 Treatment of renal diseases with ace inhibitors |
| 08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
| 08/24/1993 | US5238922 Inhibitors of farnesyl protein transferase |
| 08/24/1993 | US5238921 Oligopeptide, angiotensin converting enzyme inhibitors, hypotensive agent, and method for treatment of hypertension |
| 08/24/1993 | US5238920 Pulmonary surfactant protein fragments |
| 08/24/1993 | US5238919 Amino acid sequences corresponding to von Willebrand factor fragments; inhibit binding to platelets, heparin, collagen |
| 08/24/1993 | US5238917 High-absorbable transvaginal preparation containing biologically active polypeptide |
| 08/24/1993 | US5238916 Stimulates proliferation of mesodermal cells and growth of capillaries, promotes tissue repair |
| 08/24/1993 | US5238839 Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells |
| 08/24/1993 | US5238837 Antiinflammatory agents, antiulcer agents |
| 08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
| 08/24/1993 | US5238689 Use of ruthenium red as immunosuppressive agents |
| 08/24/1993 | US5238683 Pulmonary disorders |
| 08/24/1993 | CA1321676C Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| 08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
| 08/24/1993 | CA1321542C Drug, delivery compositions and methods |
| 08/19/1993 | WO1994015967A1 Agents for the prevention and treatment of parkinson's disease |
| 08/19/1993 | WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 08/19/1993 | WO1993016192A1 Humanised antibody against hepatitis |
| 08/19/1993 | WO1993016191A1 Empty major histocompatibility class ii heterodimers |
| 08/19/1993 | WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
| 08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | WO1993016181A1 A 90k tumor-associated antigen, ir-95 |
| 08/19/1993 | WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING |
| 08/19/1993 | WO1993016107A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 08/19/1993 | WO1993016106A1 Novel megakaryocyte amplifier and production thereof |
| 08/19/1993 | WO1993016105A1 Phenylalanine analogs of bombesin |
| 08/19/1993 | WO1993016104A1 New hexapeptidic derivatives, preparation, method and application as medicaments of said new derivatives |
| 08/19/1993 | WO1993016103A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 08/19/1993 | WO1993016101A1 Beta-amyloid peptide production inhibitors and methods for their identification |
| 08/19/1993 | WO1993016100A2 Calmodulin-binding peptides |
| 08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
| 08/19/1993 | WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | WO1993015770A1 Radiolabelled peptide compounds |
| 08/19/1993 | WO1993015766A1 Desensitization to specific allergens |
| 08/19/1993 | WO1993015764A1 Treatment for inflammatory bowel disease |
| 08/19/1993 | WO1993015761A1 Malaria treatments |
| 08/19/1993 | WO1993015757A1 Antidote for hirudin and synthetic thrombin inhibitors |
| 08/19/1993 | WO1993015756A1 Inhibitors of thrombosis |
| 08/19/1993 | WO1993015755A1 Protease-resistant thrombomodulin analogs |
| 08/19/1993 | WO1993015752A1 Anti-neuropathic composition |
| 08/19/1993 | WO1993015751A1 CHIMERIC TOXINS BINDING TO THE GnRH RECEPTOR |
| 08/19/1993 | WO1993015750A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | WO1993015747A1 A method of using cd4-containing molecules to substantially reduce the risk of occupational hiv transmission |
| 08/19/1993 | WO1993015743A1 Novel gene therapies employing antisense constructs |
| 08/19/1993 | WO1993015725A1 Compositions and processes for the sustained release of drugs |
| 08/19/1993 | WO1993015609A1 Interferon gene therapy for the treatment of vascular disorders |